ATE235485T1 - Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahren - Google Patents
Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahrenInfo
- Publication number
- ATE235485T1 ATE235485T1 AT99934643T AT99934643T ATE235485T1 AT E235485 T1 ATE235485 T1 AT E235485T1 AT 99934643 T AT99934643 T AT 99934643T AT 99934643 T AT99934643 T AT 99934643T AT E235485 T1 ATE235485 T1 AT E235485T1
- Authority
- AT
- Austria
- Prior art keywords
- dyslipidemia
- diabetes
- treatment
- atheriosclerosis
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9809164A FR2781222A1 (fr) | 1998-07-17 | 1998-07-17 | Composes cycliques utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procede de preparation |
| PCT/EP1999/004831 WO2000004011A1 (en) | 1998-07-17 | 1999-07-09 | Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE235485T1 true ATE235485T1 (de) | 2003-04-15 |
Family
ID=9528730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99934643T ATE235485T1 (de) | 1998-07-17 | 1999-07-09 | Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahren |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6528538B1 (de) |
| EP (1) | EP1098893B1 (de) |
| JP (1) | JP2002520407A (de) |
| KR (1) | KR20010070966A (de) |
| CN (1) | CN1309655A (de) |
| AT (1) | ATE235485T1 (de) |
| AU (1) | AU753287B2 (de) |
| BR (1) | BR9912138A (de) |
| CA (1) | CA2337481A1 (de) |
| DE (1) | DE69906303T2 (de) |
| DK (1) | DK1098893T3 (de) |
| ES (1) | ES2192853T3 (de) |
| FR (1) | FR2781222A1 (de) |
| HK (1) | HK1039615A1 (de) |
| HU (1) | HUP0103411A3 (de) |
| ID (1) | ID27854A (de) |
| NO (1) | NO20010266L (de) |
| PL (1) | PL345397A1 (de) |
| PT (1) | PT1098893E (de) |
| SK (1) | SK482001A3 (de) |
| WO (1) | WO2000004011A1 (de) |
| ZA (1) | ZA200101303B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI311133B (en) | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
| EP1452521A4 (de) * | 2001-08-17 | 2007-03-14 | Eisai R&D Man Co Ltd | Cyclische verbindung und ppar-agonist |
| DK1622569T3 (en) | 2003-04-24 | 2015-12-14 | Incyte Holdings Corp | AZA-SPIRO-alkane derivatives as inhibitors of metalloproteases |
| CN1930152A (zh) * | 2004-01-09 | 2007-03-14 | 卡地拉健康护理有限公司 | 用于治疗i.a.肥胖症和糖尿病的1,3－二噁烷衍生物及其类似物 |
| WO2006018855A1 (en) * | 2004-08-20 | 2006-02-23 | Cadila Healthcare Limited | Novel antidiabetic compounds |
| CN100389112C (zh) * | 2004-12-16 | 2008-05-21 | 中国石油化工股份有限公司 | 一类环状缩醛和缩酮化合物及其应用 |
| JP5009314B2 (ja) * | 2006-02-27 | 2012-08-22 | カディラ・ヘルスケア・リミテッド | １，３−ジオキサンカルボン酸 |
| KR20090010035A (ko) * | 2006-05-18 | 2009-01-28 | 웰스태트 테러퓨틱스 코포레이션 | 물질대사 장애의 치료용 화합물 |
| WO2007143600A2 (en) * | 2006-06-05 | 2007-12-13 | Incyte Corporation | Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases |
| WO2016056031A1 (en) | 2014-10-08 | 2016-04-14 | Council Of Scientific & Industrial Research | Novel diol compounds synthesis and its use for formal synthesis of (2r, 3 s)-3-hydroxypipecolic acid |
| US9637575B2 (en) | 2014-12-31 | 2017-05-02 | W. R. Grace & Co. -Conn. | Catalyst system, olefin polymerization catalyst components comprising at least an internal electron donor compound, and methods of making and using the same |
| EP4073021A4 (de) * | 2019-12-13 | 2024-02-28 | Specialty Operations France | Herstellung von benzolderivaten |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4032536A (en) | 1976-07-22 | 1977-06-28 | Janssen Pharmaceutica N.V. | (1h-benzimidazol-2-yl)carbamates |
| US5179216A (en) * | 1990-08-16 | 1993-01-12 | American Home Products Corporation | N,n', n'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-coa:cholesterol-acyl transferase |
| TW209868B (de) * | 1991-04-04 | 1993-07-21 | Yoshitomi Pharmaceutical | |
| DE19637840A1 (de) * | 1996-09-17 | 1998-03-19 | Henkel Kgaa | Verwendung von geminalen Dialkoxyalkansäureestern zur Herstellung von desodorierenden Körperpflegemitteln |
-
1998
- 1998-07-17 FR FR9809164A patent/FR2781222A1/fr not_active Withdrawn
-
1999
- 1999-07-09 KR KR1020017000647A patent/KR20010070966A/ko not_active Application Discontinuation
- 1999-07-09 US US09/743,759 patent/US6528538B1/en not_active Expired - Fee Related
- 1999-07-09 DK DK99934643T patent/DK1098893T3/da active
- 1999-07-09 DE DE69906303T patent/DE69906303T2/de not_active Expired - Fee Related
- 1999-07-09 PL PL99345397A patent/PL345397A1/xx unknown
- 1999-07-09 BR BR9912138-7A patent/BR9912138A/pt not_active IP Right Cessation
- 1999-07-09 CA CA002337481A patent/CA2337481A1/en not_active Abandoned
- 1999-07-09 CN CN99808783A patent/CN1309655A/zh active Pending
- 1999-07-09 WO PCT/EP1999/004831 patent/WO2000004011A1/en not_active Application Discontinuation
- 1999-07-09 EP EP99934643A patent/EP1098893B1/de not_active Expired - Lifetime
- 1999-07-09 PT PT99934643T patent/PT1098893E/pt unknown
- 1999-07-09 SK SK48-2001A patent/SK482001A3/sk unknown
- 1999-07-09 HU HU0103411A patent/HUP0103411A3/hu unknown
- 1999-07-09 ES ES99934643T patent/ES2192853T3/es not_active Expired - Lifetime
- 1999-07-09 AU AU50347/99A patent/AU753287B2/en not_active Ceased
- 1999-07-09 JP JP2000560117A patent/JP2002520407A/ja active Pending
- 1999-07-09 ID IDW20010261A patent/ID27854A/id unknown
- 1999-07-09 AT AT99934643T patent/ATE235485T1/de not_active IP Right Cessation
-
2001
- 2001-01-16 NO NO20010266A patent/NO20010266L/no not_active Application Discontinuation
- 2001-02-15 ZA ZA200101303A patent/ZA200101303B/en unknown
-
2002
- 2002-02-07 HK HK02100966.8A patent/HK1039615A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010070966A (ko) | 2001-07-28 |
| EP1098893A1 (de) | 2001-05-16 |
| US6528538B1 (en) | 2003-03-04 |
| AU753287B2 (en) | 2002-10-17 |
| NO20010266D0 (no) | 2001-01-16 |
| ZA200101303B (en) | 2002-05-15 |
| SK482001A3 (en) | 2001-09-11 |
| DK1098893T3 (da) | 2003-07-07 |
| FR2781222A1 (fr) | 2000-01-21 |
| ID27854A (id) | 2001-04-26 |
| HK1039615A1 (zh) | 2002-05-03 |
| CA2337481A1 (en) | 2000-01-27 |
| DE69906303T2 (de) | 2003-12-11 |
| HUP0103411A3 (en) | 2002-08-28 |
| EP1098893B1 (de) | 2003-03-26 |
| HUP0103411A2 (hu) | 2002-04-29 |
| JP2002520407A (ja) | 2002-07-09 |
| WO2000004011A1 (en) | 2000-01-27 |
| AU5034799A (en) | 2000-02-07 |
| PT1098893E (pt) | 2003-08-29 |
| PL345397A1 (en) | 2001-12-17 |
| DE69906303D1 (de) | 2003-04-30 |
| BR9912138A (pt) | 2001-04-10 |
| NO20010266L (no) | 2001-01-16 |
| CN1309655A (zh) | 2001-08-22 |
| ES2192853T3 (es) | 2003-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005014955D1 (de) | Verbindungen und verfahren zur behandlung von dyslipidämie | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| DE60214179D1 (de) | IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN | |
| GB0305152D0 (en) | Organic compounds | |
| AP2003002915A0 (en) | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis. | |
| MXPA03009840A (es) | Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos. | |
| ATE235485T1 (de) | Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahren | |
| TW200519106A (en) | Organic compounds | |
| SE0202133D0 (sv) | Novel compounds | |
| ATE424385T1 (de) | 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2- one derivate und verwandte verbindungen als nociceptin analoge und orl1 liganden zur behandlung von schmerz | |
| ATE457027T1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht | |
| SE0301368D0 (sv) | Chemical compounds | |
| PL354030A1 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
| DE60326358D1 (de) | Fasern und fibride enthaltende artikel, fasern und fibride und herstellungsverfahren | |
| SE0200844D0 (sv) | Chemical compounds | |
| MXPA04000036A (es) | Benzofuranos sustituidos con (hetero) arilo como ligandos 5-ht. | |
| SE0200843D0 (sv) | Chemical compounds | |
| DE602004021363D1 (de) | Imidazotriazin verbindungen zur behandlung von krebserkrankungen | |
| DE69429856D1 (de) | Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit | |
| DE50010285D1 (de) | Verwendung von polycyclischen 2-amino-thiazol systemen zur herstellung von medikamenten zur behandlung von fettstoffwechselstörungen, obesitas und typ ii diabetes | |
| HUP0302408A2 (hu) | Új aminotriazolon-vegyületek, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények | |
| CY1110156T1 (el) | Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης | |
| DE602004023102D1 (de) | Verfahren zur herstellung kristalliner formen von orlistat | |
| ATE417831T1 (de) | Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel | |
| ATE274513T1 (de) | Verbindungen und verfahren zur behandlung von schmerz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1098893 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |